Introduction
Obstructive sleep apnea-hypopnea syndrome (OSAHS) is a widespread chronic condition characterized by sleep fragmentation at its core, in which the patient’s upper airway partially or completely collapses as you sleep, resulting in recurrent hypoventilation (partial cessation of breathing) or respiratory apnea (complete respiratory arrest).1 The prevalence ranges from 9% to 38% globally.2 With 176 million patients, China has the most OSAHS sufferers worldwide.3 Because of its strong correlation with metabolic problems,4 cardiovascular diseases,5–7 and neurocognitive impairment,8,9 it has become a significant public health concern.
Excessive daytime sleepiness and impaired cognitive, social, and physical function are common in people with OSAHS. They deal with low job performance, despair, and rising…